Edition:
India

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

444.00INR
12:50pm IST
Change (% chg)

Rs-5.80 (-1.29%)
Prev Close
Rs449.80
Open
Rs453.95
Day's High
Rs456.60
Day's Low
Rs442.55
Volume
2,847,642
Avg. Vol
7,877,262
52-wk High
Rs573.05
52-wk Low
Rs161.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Mar '20 27,674.90 7.810
Dec 27,355.60 6.760
Sep 28,150.40 9.060
Jun 23,228.80 3.873
FY 2019 Mar '19 25,634.70 6.720
Dec 25,550.40 4.120
Sep 25,813.30 14.670
Jun 21,656.20 8.260
FY 2018 Mar '18 22,798.20 5.348
Dec 22,036.60 3.310
Sep 22,565.90 7.242
Jun 23,630.00 11.534
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-20 2 28,457.90 28,827.70 28,088.00 --
Quarter Ending Mar-20 11 26,698.70 28,708.00 25,200.00 --
Year Ending Mar-20 19 105,293.00 107,990.00 102,372.00 --
Year Ending Mar-21 22 114,105.00 117,989.00 110,169.00 120,867.00
Year Ending Mar-22 22 124,763.00 131,097.00 118,121.00 131,194.00
Earnings (per share)
Quarter Ending Dec-20 2 7.64 7.75 7.54 --
Quarter Ending Mar-20 6 5.86 8.97 3.20 --
Year Ending Mar-20 21 25.51 28.30 20.77 --
Year Ending Mar-21 23 27.76 36.50 20.10 38.08
Year Ending Mar-22 23 33.73 44.50 25.80 42.96
LT Growth Rate (%) 1 17.10 17.10 17.10 12.20
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 16.45 32.82 36.16
P/E High - Last 5 Yrs. 31.80 43.17 46.25
P/E Low - Last 5 Yrs. 7.49 25.29 25.23
Beta 1.31 0.95 0.93
Price to Sales (TTM) 1.20 4.38 9.02
Price to Book (MRQ) 2.10 4.21 4.59
Price to Tangible Book (MRQ) 3.28 5.06 5.81
Price to Cash Flow (TTM) 10.70 24.18 30.71
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 0.44 1.57 1.47
Dividend Yield - 5 Year Avg 0.35 0.90 0.90
Dividend 5 Year Growth Rate 4.56 3.90 4.69
Payout Ratio(TTM) 9.09 51.07 48.10

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.96 14.64 12.55
Sales (TTM) vs TTM 1 Yr. Ago 7.86 14.86 14.12
Sales - 5 Yr. Growth Rate 9.93 5.88 6.15
EPS (MRQ) vs Qtr. 1 Yr. Ago 16.22 88.55 64.09
EPS (TTM) vs TTM 1 Yr. Ago -18.56 -- --
EPS - 5 Yr. Growth Rate 9.44 8.49 8.74
Capital Spending - 5 Yr. Growth Rate 11.37 13.08 12.98

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.13 2.46 2.47
Current Ratio (MRQ) 1.65 3.25 3.27
LT Debt to Equity (MRQ) 66.60 11.59 13.83
Total Debt to Equity (MRQ) 73.89 16.70 19.23
Interest Coverage (TTM) 3.87 10.72 11.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 65.24 54.75 54.55
Gross Margin - 5 Yr. Avg. 64.85 54.68 54.26
EBITD Margin (TTM) 15.96 -- --
EBITD - 5 Yr. Avg 18.51 19.14 12.79
Operating Margin (TTM) 12.35 14.68 -6.74
Operating Margin - 5 Yr. Avg. 14.27 14.85 7.92
Pre-Tax Margin (TTM) 10.30 15.05 -7.84
Pre-Tax Margin - 5 Yr. Avg. 12.33 15.13 8.11
Net Profit Margin (TTM) 7.29 11.29 -11.59
Net Profit Margin - 5 Yr. Avg. 8.81 11.46 4.53
Effective Tax Rate (TTM) 29.20 17.64 18.41
Effective Tax Rate - 5 Yr. Avg. 28.55 22.18 22.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 987,114,156 856,900,747
Net Income/Employee (TTM) -- 110,726,874 96,037,654
Receivable Turnover (TTM) 4.62 5.56 6.39
Inventory Turnover (TTM) 1.69 2.70 3.54
Asset Turnover (TTM) 0.76 0.82 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.55 10.43 9.86
Return on Assets - 5 Yr. Avg. 6.65 11.15 10.69
Return on Investment (TTM) 7.82 13.08 12.50
Return on Investment - 5 Yr. Avg. 9.38 13.95 13.38
Return on Equity (TTM) 13.29 14.35 13.92
Return on Equity - 5 Yr. Avg. 16.41 16.79 16.14
  1 Year 3 Year 5 Year
Sales % 7.86 5.02 9.93
EPS (TTM) % -16.11 -5.37 9.44
Dividend % 25.00 7.72 4.56
Note: Units in Millions of US Dollars

Performance for Glenmark Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.54 0.13 99 63
13 Week 34.21 20.33 99 48
26 Week 45.83 57.91 99 76
52 Week 6.89 5.22 99 76
YTD 30.19 42.82 99 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.31%
# of Holders: 86
Total Shares Held: 68,586,684
3 Mo. Net Change: -3,659,757
# New Positions: 4
# Closed Positions: 13
# Increased Positions: 14
# Reduced Positions: 32
# Net Buyers: -18
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.